TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2025
Back to search
Official data from USPTO
HUB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
11/02/2025
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
11/29/2018
Registration date
05/12/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2020
Last transaction
11/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
78
Owner location
NL
Examiner
MOLINOFF,JEFFREY S.
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consist of the teal stylized wording "HUB" and a stylized outline design of cells in shades of teal. The white inside the cells is background only and is not claimed as a feature of the mark.
Holders and representatives
Holders
HUB Organoids IP B.V.
HUB Organoids B.V. IP
S. T. (pessoa física)
Representatives
William C. Wright Epstein Drangel LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cellsstem cellsepithelial cellsall for scientific research purposes; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell culturesfor scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes
Class 5
Cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; stem cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; stem cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; epithelial cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; epithelial cells for medical and veterinary diagnostic and therapeutic purposesnamely for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cell cultures for medical and veterinary diagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cell cultures for medical and veterinary diagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cellscultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx
Class 42
Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compounddrug and vaccine discoverydevelopment servicescharacterization and validation services in the nature of product quality and efficacy testing for medical compoundsdrugs and vaccines; candidate drug and vaccinedrug and vaccine testing servicestesting of pharmaceuticals; companion diagnosticsthe scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine
Class 44
Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
Publications
History of USPTO decisions and trademark events.
53 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/28/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/28/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/28/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/12/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/07/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/15/2020
FIMP
FINAL DISPOSITION PROCESSED
09/15/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2020
PUBO
PUBLISHED FOR OPPOSITION
02/25/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/22/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/05/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
01/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
01/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/17/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/14/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
12/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/17/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/17/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/17/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/01/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2019
RFNT
REFUSAL PROCESSED BY IB
06/28/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2019
RFRR
REFUSAL PROCESSED BY MPU
06/10/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/29/2019
CNRT
NON-FINAL ACTION WRITTEN
05/28/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/14/2019
DOCK
ASSIGNED TO EXAMINER
05/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/09/2019
Continuous trademark protection
Get notified about every new filing that threatens HUB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.